Scarica l'app Stockscreener
35.73
0.50%
-0.18
Dopo l'orario di chiusura:
35.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$35.91
Aprire:
$35.87
Volume 24 ore:
386.26K
Relative Volume:
0.44
Capitalizzazione di mercato:
$15.24B
Reddito:
$5.81B
Utile/perdita netta:
$412.00M
Rapporto P/E:
38.01
EPS:
0.94
Flusso di cassa netto:
-
1 W Prestazione:
-1.54%
1M Prestazione:
-6.20%
6M Prestazione:
+39.30%
1 anno Prestazione:
+24.06%
Intervallo 1D:
$35.66
$35.98
Intervallo di 1 settimana:
$35.66
$36.83
Portata 52W:
$23.69
$38.79
Smith Nephew Plc Adr Stock (SNN) Company Profile
Nome
Smith Nephew Plc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta SNN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
35.73 | 15.24B | 5.81B | 412.00M | 0 | 0.94 |
|
ABT
Abbott Laboratories
|
133.02 | 232.77B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.90 | 143.29B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.24 | 140.03B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
98.33 | 126.25B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
76.72 | 44.95B | 5.69B | 1.41B | 577.90M | 6.9828 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-03-12 | Downgrade | UBS | Buy → Neutral |
| 2024-11-06 | Downgrade | Berenberg | Buy → Hold |
| 2024-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-07-24 | Iniziato | Deutsche Bank | Buy |
| 2024-06-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-11-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2023-11-03 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-10-31 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2023-10-13 | Iniziato | Stifel | Hold |
| 2023-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2023-04-27 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-04-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | Iniziato | Citigroup | Buy |
| 2022-11-28 | Downgrade | UBS | Neutral → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-07-28 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-04 | Aggiornamento | Redburn | Sell → Neutral |
| 2021-06-09 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | Iniziato | Barclays | Overweight |
| 2020-07-29 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | Downgrade | Citigroup | Buy → Neutral |
| 2019-11-21 | Iniziato | Citigroup | Buy |
| 2019-11-12 | Iniziato | Bernstein | Outperform |
| 2019-07-23 | Aggiornamento | Berenberg | Hold → Buy |
| 2019-02-08 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-12-10 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | Reiterato | Canaccord Genuity | Buy |
| 2018-01-25 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-12-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-27 | Downgrade | Goldman | Buy → Neutral |
| 2017-01-19 | Iniziato | HSBC Securities | Hold |
| 2016-12-08 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | Downgrade | Berenberg | Buy → Hold |
| 2016-02-26 | Iniziato | Cantor Fitzgerald | Hold |
Mostra tutto
Smith Nephew Plc Adr Borsa (SNN) Ultime notizie
PBC Biomed Appoints Mark McMahan as Chief Commercial Officer - GlobeNewswire Inc.
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention - Sahm
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty - The Globe and Mail
Park Avenue Securities LLC Acquires 583 Shares of Smith & Nephew SNATS, Inc. $SNN - Defense World
Citi Keeps Their Hold Rating on Koninklijke Philips N.V. (0LNG) - The Globe and Mail
Smith & Nephew (LON:SN) Share Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World
Smith & Nephew expands its advanced bioactives portfolio - MarketScreener
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant - Ariva
Smith & Nephew (LON:SN) Insider Simon Lowth Purchases 355 Shares - Defense World
Smith & Nephew (LON:SN) Insider Katarzyna Mazur Hofsaess Purchases 541 Shares of Stock - Defense World
FMI Global Equity Q2 2025 Review - Seeking Alpha
FMI All Cap Equity Q2 2025 Review - Seeking Alpha
FMI Large Cap Equity Q2 2025 Review (Mutual Fund:FMIHX) - Seeking Alpha
Smith & Nephew director David King buys USD100,000 in shares - MarketScreener
Smith & Nephew stock hits 52-week high at 36.56 USD - Investing.com
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for Smith & Nephew (LON:SN) Stock - Defense World
Smith & Nephew Earnings: The Turnaround Started Three Years Ago and Now Bears Fruit - Morningstar
Smith & Nephew's Turnaround Pushes Profitability Higher - Morningstar
Smith & Nephew plc ADR: Rising 11.43% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com
Smith & Nephew SNATS, Inc. (SNN) Stock Forecasts - Yahoo Finance
What Are Expectations For Smith & Nephew plc ADR (NYSE: SNN) In The Short Term? - stocksregister.com
Upwork Inc (NASDAQ: UPWK) Is Down -0.17% – Is It A Buying Opportunity? - stocksregister.com
Smith & Nephew to buy back $500 million in shares in second half 2025 - Investing.com UK
Smith & Nephew schedules release of second quarter and half-year 2025 results - Investing.com
Haleon PLC Sponsored ADR (NYSE:HLN) Shares Sold by Bank of New York Mellon Corp - Defense World
Validea's Top Health Care Stocks Based on Martin Zweig - AInvest
SNN’s 2023 Market Dance: Up 12.53% – Time to Invest? - investchronicle.com
Bessemer Group Inc. Purchases 1,701 Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) - Defense World
Smith & Nephew (LON:SN) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Smith & Nephew appoints new Non-Executive Director - Investing.com
Smith & Nephew plc: Institutional Strength and Dividend Discipline Fuel Undervalued Gem - AInvest
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹ - The Globe and Mail
Shell Plc Declares Q1 2025 Dividend - DirectorsTalk Interviews
Smith & Nephew plc ADR [SNN] Investment Appeal on the Rise - knoxdaily.com
TRI (Thomson-Reuters Corp) may reap gains as insiders became active recently - knoxdaily.com
Glaukos Corporation (GKOS) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Smith+Nephew reports solid Q1 2025 growth - Investing.com
AN Stock Sees Surge of Approximately 3.05% in Last Five Days - knoxdaily.com
Smith+Nephew schedules Q1 2025 trading report release - Investing.com
UBS cuts Smith & Nephew stock rating to Neutral, sets GBP1.25 target - Investing.com
Smith & Nephew CEO Deepak Nath's 2024 Total Pay At $7.8 Mln, Annual Report Says - MarketScreener
Weekly Stock Grader: Upgrades & Downgrades for 164 Blue Chips - InvestorPlace
FTSE 100 up; Smith & Nephew surges; BAE gets UK defence boost - Investing.com UK
Smith+Nephew to announce 2024 full year results February 25 - Investing.com
Smith+Nephew appoints new Non-Executive Director - Investing.com
Rio Tinto Plc 2025 Dividend Schedule And Key Event Dates - DirectorsTalk Interviews
World adrs in Stocks Markets - richtv.io
Smith & Nephew Sees Challenges in China Market - Morningstar
The Best Healthcare Stocks to Buy - Morningstar
Smith & Nephew stock gains on Cevian stake (NYSE:SNN) - Seeking Alpha
Smith Nephew Plc Adr Azioni (SNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):